What Is the Ceiling for IONQ Stock?
IonQ (NYSE:IONQ) is a quantum computing startup that, like many…
Sell
31
PSCH Quote, Financials, Valuation and Earnings
Last price:
$40.14
Seasonality move
:
-0.23%
Day range:
$39.97 - $40.70
52-week range:
$36.69 - $49.05
Dividend yield:
0.09%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
26.2K
Avg. volume:
12.1K
1-year change:
-9.24%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$39.97 | -- | -- | -- | $0.00 | 0.09% | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
$21.19 | -- | -- | -- | $0.24 | 1.13% | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
$61.26 | -- | -- | -- | $0.00 | 0% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$66.14 | -- | -- | -- | $0.13 | 0.25% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$88.38 | -- | -- | -- | $0.01 | 0.04% | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
$82.48 | -- | -- | -- | $0.02 | 0.06% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 1.111 | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | 1.073 | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 0.688 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.915 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 1.018 | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | 1.330 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- | -- |
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
Invesco S&P SmallCap Health Care ETF vs. Competitors
-
Which has Higher Returns PSCH or BBC?
Virtus LifeSci Biotech Clinical Trials ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat Virtus LifeSci Biotech Clinical Trials ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- -
What do Analysts Say About PSCH or BBC?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Clinical Trials ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than Virtus LifeSci Biotech Clinical Trials ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than Virtus LifeSci Biotech Clinical Trials ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 BBCVirtus LifeSci Biotech Clinical Trials ETF0 0 0 -
Is PSCH or BBC More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.958, which suggesting that the stock is 4.237% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Clinical Trials ETF has a beta of 0.982, suggesting its less volatile than the S&P 500 by 1.842%.
-
Which is a Better Dividend Stock PSCH or BBC?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.09%. Virtus LifeSci Biotech Clinical Trials ETF offers a yield of 1.13% to investors and pays a quarterly dividend of $0.24 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Clinical Trials ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or BBC?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Clinical Trials ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than Virtus LifeSci Biotech Clinical Trials ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Clinical Trials ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for Virtus LifeSci Biotech Clinical Trials ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- --
-
Which has Higher Returns PSCH or BBP?
Virtus LifeSci Biotech Products ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat Virtus LifeSci Biotech Products ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- -
What do Analysts Say About PSCH or BBP?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Products ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than Virtus LifeSci Biotech Products ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than Virtus LifeSci Biotech Products ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 BBPVirtus LifeSci Biotech Products ETF0 0 0 -
Is PSCH or BBP More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.958, which suggesting that the stock is 4.237% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Products ETF has a beta of 0.574, suggesting its less volatile than the S&P 500 by 42.58%.
-
Which is a Better Dividend Stock PSCH or BBP?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.09%. Virtus LifeSci Biotech Products ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Products ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or BBP?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Products ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than Virtus LifeSci Biotech Products ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Products ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for Virtus LifeSci Biotech Products ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- BBPVirtus LifeSci Biotech Products ETF-- -- -- --
-
Which has Higher Returns PSCH or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About PSCH or PBE?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is PSCH or PBE More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.958, which suggesting that the stock is 4.237% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.810, suggesting its less volatile than the S&P 500 by 19.007%.
-
Which is a Better Dividend Stock PSCH or PBE?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.09%. Invesco Biotechnology & Genome ETF offers a yield of 0.25% to investors and pays a quarterly dividend of $0.13 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or PBE?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns PSCH or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About PSCH or XBI?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is PSCH or XBI More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.958, which suggesting that the stock is 4.237% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.917, suggesting its less volatile than the S&P 500 by 8.345%.
-
Which is a Better Dividend Stock PSCH or XBI?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.09%. SPDR S&P Biotech ETF offers a yield of 0.04% to investors and pays a quarterly dividend of $0.01 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or XBI?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
-
Which has Higher Returns PSCH or XHE?
SPDR S&P Health Care Equipment ETF has a net margin of -- compared to Invesco S&P SmallCap Health Care ETF's net margin of --. Invesco S&P SmallCap Health Care ETF's return on equity of -- beat SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PSCHInvesco S&P SmallCap Health Care ETF-- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About PSCH or XHE?
Invesco S&P SmallCap Health Care ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco S&P SmallCap Health Care ETF has higher upside potential than SPDR S&P Health Care Equipment ETF, analysts believe Invesco S&P SmallCap Health Care ETF is more attractive than SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings PSCHInvesco S&P SmallCap Health Care ETF0 0 0 XHESPDR S&P Health Care Equipment ETF0 0 0 -
Is PSCH or XHE More Risky?
Invesco S&P SmallCap Health Care ETF has a beta of 0.958, which suggesting that the stock is 4.237% less volatile than S&P 500. In comparison SPDR S&P Health Care Equipment ETF has a beta of 1.047, suggesting its more volatile than the S&P 500 by 4.673%.
-
Which is a Better Dividend Stock PSCH or XHE?
Invesco S&P SmallCap Health Care ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0.09%. SPDR S&P Health Care Equipment ETF offers a yield of 0.06% to investors and pays a quarterly dividend of $0.02 per share. Invesco S&P SmallCap Health Care ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PSCH or XHE?
Invesco S&P SmallCap Health Care ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Equipment ETF quarterly revenues of --. Invesco S&P SmallCap Health Care ETF's net income of -- is lower than SPDR S&P Health Care Equipment ETF's net income of --. Notably, Invesco S&P SmallCap Health Care ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco S&P SmallCap Health Care ETF is -- versus -- for SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Can FUBO Stock Double?
TV streaming service Fubo (NYSE:FUBO) has seen incredible returns so…
Where Will CoreWeave Stock Be in 1 Year?
When CoreWeave (NASDAQ: CRWV) slipped below its $40 IPO price…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 43x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
58
INKT alert for Jul 12
MiNK Therapeutics [INKT] is up 727.94% over the past day.
Buy
51
NEGG alert for Jul 12
Newegg Commerce [NEGG] is up 74.03% over the past day.
Buy
68
ATRO alert for Jul 12
Astronics [ATRO] is up 16.28% over the past day.
